1-21 of 21
Keywords: non-alcoholic fatty liver disease (NAFLD)
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Articles
Clin Sci (Lond) (2015) 128 (4): 257–267.
Published: 17 October 2014
... in the abnormal chemotaxis of CXC chemokine ligand 12 (CXCL12) in several mouse models of NASH and the relevance in the context of human non-alcoholic fatty liver disease (NAFLD). We assessed chemotactic responsiveness of CD4 + T-cells to CXCL12, the effect of AMD3100, a CXC chemokine receptor 4 (CXCR4...
Includes: Supplementary data
Articles
Articles
Clin Sci (Lond) (2013) 125 (8): 391–400.
Published: 14 June 2013
...′-CTTGCGACCTTGACCATCTT-3′ (reverse); fetuin-A: 5′-CCAGTCCAGACTCAGCCCAGGA-3′ (forward), 5′-CTGAGCGTTGAAGGCGGCCA-3′ (reverse). adiponectin bariatric surgery fetuin-A non-alcoholic fatty liver disease (NAFLD) • BAS improves metabolic function and overall health, although underlying mechanisms remain...
Includes: Supplementary data
Articles
Articles
Clin Sci (Lond) (2012) 123 (5): 323–332.
Published: 16 May 2012
... non-alcoholic fatty liver disease (NAFLD) survival pathway NAFLD (non-alcoholic fatty liver disease) is characterized by lipid accumulation within the hepatocytes and is considered the hepatic manifestation of the so-called ‘metabolic syndrome’ being associated with visceral obesity, insulin...
Includes: Supplementary data
Articles
Articles
Clin Sci (Lond) (2011) 120 (7): 285–286.
Published: 13 December 2010
... in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis Hepatology 1999 29 320 327 bile acid transport bile salt export pump (BSEP) cirrhosis farnesoid X receptor (FXR) non-alcoholic fatty liver disease (NAFLD...
Articles
Articles
Articles
Clin Sci (Lond) (2010) 119 (10): 431–436.
Published: 05 August 2010
... chronic liver disease cirrhosis hepatic fibrosis metabolic syndrome non-alcoholic fatty liver disease (NAFLD) Adiponectin is a 244-amino-acid adipocytokine that plays a pivotal role in metabolic liver diseases. Adiponectin is produced by adipocytes [ 1 , 2 ] and circulates at high...
Includes: Supplementary data
Articles
Articles
Clin Sci (Lond) (2010) 118 (12): 691–705.
Published: 30 March 2010
...: Professor Derek A. Mann (email derek.mann@newcastle.ac.uk ). 3 11 2009 6 1 2010 2 2 2010 © The Authors Journal compilation © 2010 Biochemical Society 2010 fibrosis hepatocellular carcinoma ischaemia/reperfusion injury non-alcoholic fatty liver disease (NAFLD) nuclear factor...
Articles
Clin Sci (Lond) (2009) 116 (7): 539–564.
Published: 02 March 2009
...) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition. diabetes inflammation mitochondrion non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis...
Articles
Clin Sci (Lond) (2009) 116 (5): 401–402.
Published: 02 February 2009
... steatohepatitis Correspondence: Professor Chris Boesch (email chris.boesch@insel.ch ). 2 12 2008 4 12 2008 4 12 2008 © The Authors Journal compilation © 2009 Biochemical Society 2009 diabetes magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD) NMR...
Articles
Articles
Clin Sci (Lond) (2008) 115 (5): 141–150.
Published: 01 August 2008
... 1 2008 7 2 2008 © The Authors Journal compilation © 2008 Biochemical Society 2008 insulin resistance liver non-alcoholic fatty liver disease (NAFLD) non-alcoholic steatohepatitis (NASH) obesity Case reports describing the development of liver disease progressing...
Articles
Clin Sci (Lond) (2008) 115 (1): 1–12.
Published: 02 June 2008
... 98 Targher G. Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 2007 191 235 240 99 Loria P. Lonardo A. Bellentani S. Day C. P. Marchesini G. Carulli N. Non-alcoholic fatty liver disease (NAFLD...
Articles
Clin Sci (Lond) (2008) 114 (8): 543–545.
Published: 13 March 2008
... resonance spectroscopy in response to early starvation predicts individuals at risk of developing NAFLD with weight gain also remains an intriguing question. fasting fatty liver 3-hydroxybutyrate lipid 1 H-magnetic resonance spectroscopy non-alcoholic fatty liver disease (NAFLD...
Articles